-
6-{4-methoxy-3-[(3R,5S,7s)-adamantan-1-yl]phenyl}naphthalene-2-carboxylic acid
-
ChemBase ID:
154819
-
Molecular Formular:
C28H28O3
-
Molecular Mass:
412.52012
-
Monoisotopic Mass:
412.20384476
-
SMILES and InChIs
SMILES:
COc1c(cc(cc1)c1cc2c(cc(cc2)C(=O)O)cc1)[C@@]12C[C@H]3C[C@@H](C1)C[C@H](C2)C3
Canonical SMILES:
COc1ccc(cc1[C@]12C[C@@H]3C[C@@H](C2)C[C@@H](C1)C3)c1ccc2c(c1)ccc(c2)C(=O)O
InChI:
InChI=1S/C28H28O3/c1-31-26-7-6-23(21-2-3-22-12-24(27(29)30)5-4-20(22)11-21)13-25(26)28-14-17-8-18(15-28)10-19(9-17)16-28/h2-7,11-13,17-19H,8-10,14-16H2,1H3,(H,29,30)/t17-,18+,19-,28-
InChIKey:
LZCDAPDGXCYOEH-AADAIPAGSA-N
-
Cite this record
CBID:154819 http://www.chembase.cn/molecule-154819.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
6-{4-methoxy-3-[(3R,5S,7s)-adamantan-1-yl]phenyl}naphthalene-2-carboxylic acid
|
|
|
IUPAC Traditional name
|
|
Synonyms
|
6-(4-Methoxy-3-tricyclo[3.3.1.13,7]dec-1-ylphenyl)-2-naphthalenecarboxylic acid
|
6-[3-(1-Adamantyl)-4-methoxyphenyl]-2-naphthoic acid
|
CD-271
|
Differin
|
Adapalene
|
|
|
CAS Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
3.9892612
|
H Acceptors
|
3
|
H Donor
|
1
|
LogD (pH = 5.5)
|
4.938707
|
LogD (pH = 7.4)
|
3.2933044
|
Log P
|
6.4585013
|
Molar Refractivity
|
122.0719 cm3
|
Polarizability
|
49.86113 Å3
|
Polar Surface Area
|
46.53 Å2
|
Rotatable Bonds
|
4
|
Lipinski's Rule of Five
|
false
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
A7486
|
Application Adapalene, a retinoic acid analogue, is a RARβ and RARγ agonist. Adapalene inhibits proliferation and induces apoptosis in colorectal cancer cells in vitro. Adapalene gel is an efficacious treatment for acne vulgaris. Biochem/physiol Actions Retinoic acid analogue that is a RARβ and RARγ agonist (AC50 values are 2.2, 9.3, 22 and > 1000 nM for RARβ, RARγ, RARα and RXRα receptors respectively). Inhibits proliferation and induces apoptosis in colorectal cancer cells in vitro. Displays comedolytic activity. Its unique pharmacological properties make it superior to other retinoids for the treatment of acne. |
PATENTS
PATENTS
PubChem Patent
Google Patent